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21ST IEC PROCEEDINGS S45 
A new experimental model of epilepsy, described by Gross 
and Weaver [J Cardiovasc Pharmacal 1993;22(suppl 8):282-7] 
was studied. Endothelin-1 (ET), synthesized by 0. Kaurov and 
M. Smirnova (Saint Petersburg) was administered into the lateral 
ventricle of rats. ET 9 pmol/2 11-l was the threshold dose. High 
doses of ET induced death; lower doses were not effective. Be-
havior seizures and electrical activity of frontal cortex, 
amygdala, and hippocampus were recorded. Barrel rolling and 
generalized seizures were observed. Amygdala afterdischarges 
preceded the motor manifestations, which had a very short la-
tency. Intraventricular administration of trio! saponins of Ko-
rean red ginseng (before or after ET) and ginsenoside Rc inhib-
ited the seizures and significantly increased latency. Inhibition of 
ET-1-induced barrel rolling and epileptic activity of limbic struc-
tures by intracerebroventricular pretreatment with ginseng was 
dependent on the interaction of ginsenosides with the GABA-
benzodiazeine-chloride channel receptor complex (Gen Phar-
maco/1994;25:193-9). Intranasal application of ET-1 in the same 
dose did not induce barrel rolling and seizures. 
Catalepsy and Epilepsy in Rats: Common Factors? E. V. Petrova, 
E. L. J. M. van Luijtelaar, and G. D. Kuznetsova (Institute of 
Higher Nervous Activity and Neurophysiology, Moscow, Rus-
sia; and Department of Psychology, University of Nijmegen, 
Nijmegen, The Netherlands). 
The cataleptic state is characterized by the presence of mus-
cular rigidity, automatisms, and myoclonus. These symptoms 
frequently occur in epileptic patients. In animal models, a rela-
tion between catalepsy and epilepsy also is sometimes reported. 
Petrova eta!. (J Vysh Nervn Deyat 1992;42: 1009-17) showed that 
genetic cataleptic rats have an increased predisposition for epi-
leptoform activity, including signs of petit mal. In the present 
study, we investigated whether WAG/Rij rats, genetically en-
dowed with generalized spike-wave discharges (SWD) are more 
sensitive for catalepsy. 
W AG/Rij and Wistar rats, implanted with chronic EEG elec-
trodes, were recorded for 15 min; rats were exposed to photic 
stimulation of3, 10, and 25Hz for 2-min periods and several days 
later to acoustic stimulation with key ringing. 
W AG/Rij showed some behavioral signs of fear after both 
types of stimulation, and the EEG was periodically driven by the 
rhythm of the flashes; SWD were not observed. However, in the 
first 5 min after the end of the visual and auditory stimulation, 10 
and II of 13 W AG/Rij became motionless and retained an un-
comfortable pose when forced to sit on their sacrum. The num-
ber of SWD gradually increased and reached a maximum 5-10 
min after the end of the stimulation. Wistar rats remained active 
after visual and auditory stimulation and manifested no sign of 
pathology in behavior or in EEG. Genetically epileptic WAG/Rij 
are more susceptible than Wistar rats to induction of a cataleptic 
state, suggesting that the mechanisms responsible for SWD and 
for catalepsy might be related. 
Effects of Remacemide and Its Metabolite FPL 12495 on Spike-
Wave Discharges, EEG, and Behavior in Rats with Absence Epi-
lepsy. E. L. J. M. van Luijtelaar and A. M. L. Coenen (NICI, 
Department of Psychology, University of Nijmegen, Nijmegen, 
The Netherlands). 
Anticonvulsant drugs may or may not be effective against gen-
eralized absence epilepsy. Carbamazepine and phenytoin aggra-
vate spike-wave discharges (SWD) whereas valproate and ben-
zodiazepines reduce SWD. The effects of the new anticonvulsant 
remacemide on SWD are unknown, which prompted us to inves-
tigate the effects of remacemide and its active metabolite FPL 
12495 in a genetic rat model for absence epilepsy, the WAG/Rij 
strain. Number and mean duration of SWD, parameters of the 
background EEG and spontaneous behavior were measured af-
ter various oral doses of remacemide and FPL 12495. 
A decrease in the number of SWD was noted after remacemide 
administration. At the highest dose, SWD were almost com-
pletely suppressed and there were no important effects on be-
havior or on spectral content of the background EEG, suggesting 
that remacemide has few side effects and might be effective 
against absence epilepsy. A decrease in the number of SWD was 
also noted after FPL 12495 gavage, but mean duration was pro-
longed. Behavioral changes were apparent only after the highest 
dose, accompanied by changes in spectral content, suggesting 
that FPL 12495 has other central effects as well. FPL 12495 
appeared to be more potent than remacemide in all its effects. 
The effects of FPL 12495 are unusual in that no other inves-
tigated drug has yet shown a decrease in number together with an 
increase in mean duration of discharges. FPL 12495 appears to 
exert a differential action on the two commonly distinguished 
mechanisms controling number and duration. 
Opioids and Spike-Wave Discharges in Rats: Pharmacological 
Studies. E. L. J. M. van Luijtelaar, *B. Przewlocka, *W. Las6n, 
*A. Coenen, and R. Przewlocki (Department of Psychology, 
University of Nijmegen, Nijmegen, The Netherlands; and *In-
stitute of Pharmacology, Krak6w, Poland). 
Numerous studies have provided evidence for the involvement 
of opioids in the mechanisms of various forms of epilepsy. Most 
have investigated the effects of opioids in the control and genesis 
of convulsive epilepsy, whereas data on opioids mechanisms 
with respect to nonconvulsive epilepsy are almost lacking. 
Therefore, we investigated the role of the opioid subsystems in 
WAG/Rij rats, a genetic rat model of human absence epilepsy. 
Six-month-old male WAG/Rij were chronically provided with 
EEG electrodes and some with cannulas in the lateral ventricle. 
The baseline EEG was measured, and the drugs or solvent was 
injected. The EEG was recorded for I h, and the number and 
duration of spike-wave discharges (SWD) was counted. 
SWD were facilitated by the nonspecific opioid antagonist nal-
oxone (intraperitoneally), suggesting that SWD are tonically in-
hibited by the endogenous opioid system. Next, specific mu, 
delta and kappa agonists and antagonists were evaluated. The 
mu receptor agonist DAMGO increased (intracerebroventricu-
larly, i.c.v.) markedly the number of SWD, whereas DPDPE, a 
delta receptor agonist, had no effect. Three kappa agonists (i.e. v. 
or subcutaneously) U50488H, U69593, or PDII7301 dose-
dependently inhibited the number of SWD. These effects could 
be antagonized by the kappa antagonist Nor-BNI. Nor-BNI itself 
enhanced the number of SWD, but the mu antagonist naltrindole 
had no effect. 
Endogenous opioids, which act through the kappa receptors, 
tonically control the initiation of SWD. Kappa agonists, if devoid 
of psychomimetic effects, might be useful antiabsence drugs. 
Effects of Tiagabine on Spike-Wave Discharges, Behavior, and 
Spectral Content of the EEG in Rats with Absence Epilepsy. 
A.M. L. Coenen, E. L. J. M. van Luijtelaar, and E. Blezer 
(Department of Psychology, University of Nijmegen, Nijmegen, 
The Netherlands). 
The mechanism of action of the new anticonvulsant drug ti-
agabine (TGB) is reuptake inhibition of GABA. What TGB will 
do against nonconvulsive epilepsy is unclear. GABA agonists 
such as muscimol and anticonvulsants such as carbamazepine 
and phenytoin generally increase the number of spike-wave dis-
charges (SWD). We wished to verify whether TGB would also 
facilitate the number of SWD in a genetic rat model for general-
ized absence epilepsy. 
Male W AG/Rij rats with chronically implanted EEG elec-
trodes were given either 0, I, 3, or 10 mg/kg TGB intraperito-
neally. The EEG was recorded for I h before and 2 h after drug 
administration. Behavior was recorded for 30 min postdrug; am-
bulation, passive behavior, and automatic behavior were scored. 
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